Molly 5mg Tablet is a prescription medication containing Montelukast 5mg, indicated for the treatment of perennial allergic rhinitis, chronic idiopathic urticaria, and asthma. This once-daily tablet provides 24-hour therapy, with its active ingredient Montelukast, a leukotriene receptor antagonist. The mechanism of action involves inhibition of cysteinyl leukotriene-mediated effects, thereby reducing the allergic response. The product is available in a single 5mg strength tablet, which is taken orally once daily. In clinical trials, Molly 5mg Tablet demonstrated significant improvement in symptoms such as nasal congestion, sneezing, runny nose, and itchy eyes, as well as reduced need for rescue medication. Additionally, the product has been shown to be effective in reducing the frequency and severity of asthma exacerbations. The most common adverse reactions include headache, diarrhea, and stomach pain. Molly 5mg Tablet is contraindicated in patients with a history of hypersensitivity to Montelukast, and patients should consult their healthcare provider before taking this medication.